Drug Type siRNA |
Synonyms CCT 717, CCT717 |
Target |
Action antagonists, inhibitors |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists), TLE3 inhibitors(TLE family member 3, transcriptional corepressor inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Preclinical | Canada | 01 Feb 2025 |





